ED Coding & Reimbursement Alert - 2005 Issue 26
Pharmaceuticals: Doctors Welcome Competitive Drug Demo
Subscribe or sign in to view the full article.
Article Overview
This article discusses physician opinions on Medicare’s Competitive Acquisition Program, including how the program works at a high level, which specialties and drug categories may be most affected, and what survey respondents thought about access and administration. It is useful for clinicians, practice managers, and healthcare coding or reimbursement professionals who want a broad understanding of the policy and market context around physician-office drugs.
Why This Topic Matters
Changes in drug acquisition and billing pathways can affect physician office operations, drug availability, and specialty practice economics, especially in areas such as oncology where office-administered medications are common.
What You Will Learn
- How physicians viewed the Competitive Acquisition Program in general
- Which practice areas were thought to be most affected
- What broader drug categories were mentioned in connection with the program
- How survey results were used to characterize physician sentiment
Who Should Read This
- Physicians
- Oncology practices
- Practice administrators
- Reimbursement professionals
- Healthcare policy readers
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com